Back to search
Multiple Myeloma or Plasmacytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Myeloma or Plasmacytoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Myeloma or Plasmacytoma trials you may qualify forThe aim of this clinical trial is to assess the feasibility, safety, and efficacy of CAR-T cell therapy targeting multiple cancer cell antigens in high-risk mul…
The purpose of this study is to determine the feasibility, safety, and efficacy of dendritic cell (DC) vaccines in the treatment of multiple myeloma (MM) or pla…
This study is a 2-part study with a dose-escalation part and a dose-expansion part. The aim of the dose-escalation part is to determine the maximum tolerated do…
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leuke…
This phase I trial studies the side effects and best dose of MDM2 Inhibitor KRT-232 when given together with carfilzomib, lenalidomide, and dexamethasone in tre…